Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ecosystem and strengthen health security
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
Over a two-decade career, Dr. Berman has worked on more than a dozen clinical-stage immunotherapies, including senior leadership roles in developing four oncology biologics
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
EMA recommended 30 veterinary medicines for marketing authorisation in 2025
India’s pharmaceutical sector stands at a pivotal inflection point
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
Elanco expects Befrena to launch in the US in the first half of 2026
Subscribe To Our Newsletter & Stay Updated
